Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.40 |
| ▸ | PTPRC | P08575 | 2/20 | 0.40 |
| ▸ | PTPRF | P10586 | 1/20 | 0.40 |
| ▸ | CDC25B | P30305 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 2/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.33 |
| ▸ | BACE1 | P56817 | 2/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29555282 | 0.89 | PTPN1 (0.47) | PTPN1PTPRCPTPRFCDC25BBACE1 | |
| SCHEMBL28887375 | 0.76 | PTPN1 (0.34) | PTPN1PTPRCPTPRFCDC25BALDH1A1 | |
| SCHEMBL17047977 | 0.74 | CYP3A4 (0.38) | CYP3A4TDP1PTPN1PTPRCPTPRF | |
| SCHEMBL29860849 | 0.74 | PTPN1 (0.35) | PTPN1PTPRCPTPRFCDC25BBACE1 | |
| Hydrochloric Acid SCHEMBL4804358 | 0.72 | CYP3A4 (0.43) | CYP3A4TDP1PTPN1PTPRCPTPRF | |
| SCHEMBL4215127 | 0.69 | CYP3A4 (0.52) | CYP3A4TDP1ESR1ESR2 | |
| SCHEMBL6886030 | 0.69 | CYP3A4 (0.75) | CYP3A4TDP1ESR1ESR2ALDH1A1 | |
| SCHEMBL1258556 | 0.69 | CYP3A4 (0.75) | CYP3A4TDP1ESR1ESR2ALDH1A1 | |
| SCHEMBL28390312 | 0.69 | CYP3A4 (0.75) | CYP3A4TDP1ESR1ESR2ALDH1A1 | |
| SCHEMBL31539924 | 0.66 | CYP3A4 (0.71) | CYP3A4TDP1ESR1ESR2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2864341-B1 | METHOD FOR PREPARATION OF A RUTHENIUM INDENYLIDENE COMPLEX | UMICORE AG & CO KG (DE) | 2018-09-26 | — | — | EP | disclosed |
| EP-2679593-B1 | Method for preparation of a ruthenium indenylidene complex | UMICORE AG & CO KG (DE) | 2018-03-21 | — | — | EP | disclosed |
| US-9604205-B2 | Method for preparation of a ruthenium indenylidene complex | UMICORE AG & CO. KG (DE) | 2017-03-28 | — | — | US | disclosed |
| US-20170043332-A1 | Method for Preparation of a Ruthenium Indenylidene Complex | UMICORE AG & CO KG (DE) | 2017-02-16 | — | — | US | disclosed |
| US-20160228864-A1 | Method for Preparation of a Ruthenium Indenylidene Complex | UMICORE AG & CO KG (DE) | 2016-08-11 | — | — | US | disclosed |
| US-9339804-B2 | Method for preparation of a ruthenium indenylidene complex | UMICORE AG & CO. KG (DE) | 2016-05-17 | — | — | US | disclosed |
| US-20150190795-A1 | Method for Preparation of a Ruthenium Indenylidene Complex | UMICORE AG & CO. KG (DE) | 2015-07-09 | — | — | US | disclosed |
| WO-2008102157-A1 | CATALYTIC METHOD | THE UNIVERSITY OF BRISTOL (GB) | 2008-08-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150190795-A1 | Method for Preparation of a Ruthenium Indenylidene Complex | RPL3, RPL13A, PRPF3 | CYP3A4 694/4885TDP1 2605/4885PTPN1 4247/4885 |
| US-20160228864-A1 | Method for Preparation of a Ruthenium Indenylidene Complex | RPL3, RPL13A, UPP1 | CYP3A4 684/4885TDP1 2613/4885PTPN1 4237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.